- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
Choose Your Country or Region
Australia
Austria
Belgium
Brazil
Canada
China
Czech Republic
Denmark
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Ireland
Israel
Italy
Japan
Korea
Luxembourg
Malaysia
Netherlands
New Zealand
Norway
Poland
Qatar
Romania
Saudi Arabia
Singapore
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
United States
Synonyms: PY314
Anti-TREM2 (Py314) is a humanized monoclonal antibody that specifically targets the triggering receptor expressed on myeloid cells 2 (TREM2). It can be used in cancer research and in treatment of variety of solid tumor types. MW :145.24 KD.
| Description |
Anti-TREM2 (Py314) is a humanized monoclonal antibody that specifically targets the triggering receptor expressed on myeloid cells 2 (TREM2). It can be used in cancer research and in treatment of variety of solid tumor types. MW :145.24 KD.
|
References |
|---|
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|
| Isotype | Human IgG1 |
|---|---|
| Source | CHO |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.